Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.
Icanic Brands (OTC: ICNAF) (OTC: ICAN) Investors Discovery Day: October 27, 2020 Discover Tomorrow’s Winning Stocks! Thank you for subscribing. Something went wrong. Get our latest stock reports before everyone else! Actionable news, and breakout […]
Canaccord Genuity 2nd Annual U.S. Cannabis Symposium Conference on October 3, 2019 in Toronto, Canada- Alliance Global Partners Consumer Cannabis Conference on October 3, 2019 in New York City- Company to share its growth strategy […]
Discover Tomorrow’s Winning Stocks! Thank you for subscribing. Something went wrong. Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox. […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
